Pfizer reaches agreement with Brazilian company to produce it COVID-19 vaccine for Latin America

By Rubén Morales Iglesias: Pfizer and BioNTech have reached an agreement with a Brazilian biopharmaceutical company to mass-produce it COVID-19 vaccine, now officially known as Comirnaty, for Latin American countries, though that won’t be until 2022, according to the Miami Herald.

The deal with Eurofarma Laboratórios SA is expected to produce over 100 million doses annually for Latin American countries that have and will have bilateral agreements with Pfizer countries.

Pfizer and BioNTech already have bilateral agreements with 13 Latin American countries, namely Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Honduras, Mexico, Panama, Paraguay, Peru, and Uruguay.

The transfer of the technology and expertise, and the installation of equipment to Eurofarma’s facility in São Paulo, Brazil is expected to begin right away, but actual manufacturing of finished doses will not start until 2022 said Pfizer in a press release.

According to Bloomberg, the vaccine will be produced in the United States, sent to Eurofarma in Brazil, which will carry out the so-called fill-and-finish process of placing the vaccine into sterile vials. The vaccines will then be distributed to Latin American countries.

Carlos Murillo, Pfizer’s Latin America president, said Pfizer’s partnership with Eurofarma forms part of Pfizer’s objective of better supporting the global need for vaccines.

Murillo said that while the financial terms remain confidential, high and middle-income countries will pay a higher price than low-income countries.

“Low and lower-middle-income countries will pay a not-for-profit price,” Murilo said.

Advertise with the mоѕt vіѕіtеd nеwѕ ѕіtе іn Belize ~ We offer fully customizable and flexible digital marketing packages. Your content is delivered instantly to thousands of users in Belize and abroad! Contact us at mаrkеtіng@brеаkіngbеlіzеnеwѕ.соm or call us at 501-612-0315.

© 2021, BreakingBelizeNews.com. Content is copyrighted and requires written permission for reprinting in online or print media. Theft of content without permission/payment is punishable by law.